Tofacitinib: a janus kinase inhibitor for rheumatoid arthritis. Issue 8 (August 2017)
- Record Type:
- Journal Article
- Title:
- Tofacitinib: a janus kinase inhibitor for rheumatoid arthritis. Issue 8 (August 2017)
- Main Title:
- Tofacitinib: a janus kinase inhibitor for rheumatoid arthritis
- Authors:
- Chaplin, Steve
- Abstract:
- Abstract : Tofacitinib (Xeljanz) is an oral janus kinase (JAK) inhibitor indicated for the second‐line treatment of moderate to severe active rheumatoid arthritis in adults. This article discusses its properties, efficacy and adverse effects.
- Is Part Of:
- Prescriber. Volume 28:Issue 8(2017)
- Journal:
- Prescriber
- Issue:
- Volume 28:Issue 8(2017)
- Issue Display:
- Volume 28, Issue 8 (2017)
- Year:
- 2017
- Volume:
- 28
- Issue:
- 8
- Issue Sort Value:
- 2017-0028-0008-0000
- Page Start:
- 30
- Page End:
- 32
- Publication Date:
- 2017-08
- Subjects:
- Chemotherapy -- Periodicals
Drugs -- Prescribing -- Periodicals
615.1 - Journal URLs:
- http://www.prescriber.co.uk/view/0/index.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/psb.1602 ↗
- Languages:
- English
- ISSNs:
- 0959-6682
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6609.700100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4570.xml